Purpose: To investigate the etiology and management of male iatrogenic urethral stricture in China. Methods: The data of 172 patients with iatrogenic urethral stricture who underwent treatment at a high volume reference center in China from January 2008 to February 2014 were analyzed retrospectively. Databases were analyzed to understand the impact of different types of iatrogenic injury on stricture location, length and treatment of urethral strictures, as well as success rates. Results: The most common type of iatrogenic stricture was urethral instrumentations in 80 patients (46.51%). Mean stricture length was 3.3 ± 2.54 cm and the longest strictures were those caused by intravesical instillation. Substitution urethroplasty was the most common intervention and was performed in 60.47% (104/172) of patients. The overall success rate was 85.00% (136/160). Univariable analyses revealed that the type of iatrogenic injury was significantly related to restenosis (p = 0.036), and it is more apt to postoperative restenosis in the type of intravesical instillation than others. Conclusion: Our results showed that urethral instrumentation is the most common etiology of iatrogenic urethral stricture, and most iatrogenic urethral strictures involve the anterior urethra. The different etiologies are closely associated with stricture location, length and the overall prognosis of urethral strictures.

Keywords:
Treatment outcome, Etiology, Urethral stricture
1.
Palminteri E, Berdondini E, Verze P, De Nunzio C, Vitarelli A, Carmignani L: Contemporary urethral stricture characteristics in the developed world. Urology 2013;81:191-196.
2.
Lumen N, Hoebeke P, Willemsen P, De Troyer B, Pieters R, Oosterlinck W: Etiology of urethral stricture disease in the 21st century. J Urol 2009;182:983-987.
3.
Mathur R, Aggarwal G, Satsangi B, Khan F, Odiya S: Comprehensive analysis of etiology on the prognosis of urethral strictures. Int Braz J Urol 2011;37:362-369; discussion 369-370.
4.
Santucci RA, Joyce GF, Wise M: Male urethral stricture disease. J Urol 2007;177:1667-1674.
5.
Rassweiler J, Teber D, Kuntz R, Hofmann R: Complications of transurethral resection of the prostate (TURP) - incidence, management, and prevention. Eur Urol 2006;50:969-979; discussion 980.
6.
Kashefi C, Messer K, Barden R, Sexton C, Parsons JK: Incidence and prevention of iatrogenic urethral injuries. J Urol 2008;179:2254-2257; discussion 2257-2258.
7.
Tascı AI, Ilbey YO, Tugcu V, Cicekler O, Cevik C, Zoroglu F: Transurethral resection of the prostate with monopolar resectoscope: single-surgeon experience and long-term results of after 3589 procedures. Urology 2011;78:1151-1155.
8.
Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR: Incidence of urethral stricture after primary treatment for prostate cancer: data from capsure. J Urol 2007;178:529-534; discussion 534.
9.
Mangera A, Chapple CR: Urethral stricture disease. Surgery (Oxford) 2014;32:304-309.
10.
Stein DM, Thum DJ, Barbagli G, Kulkarni S, Sansalone S, Pardeshi A, Gonzalez CM: A geographic analysis of male urethral stricture aetiology and location. BJU Int 2013;112:830-834.
11.
Tritschler S, Roosen A, Füllhase C, Stief CG, Rübben H: Urethral stricture: etiology, investigation and treatments. Dtsch Arztebl Int 2013;110:220-226.
12.
Mundy AR, Andrich DE: Urethral strictures. BJU Int 2011;107:6-26.
13.
Naudé AM, Heyns CF: What is the place of internal urethrotomy in the treatment of urethral stricture disease? Nat Clin Pract Urol 2005;2:538-545.
14.
Mangera A, Patterson JM, Chapple CR: A systematic review of graft augmentation urethroplasty techniques for the treatment of anterior urethral strictures. Eur Urol 2011;59:797-814.
15.
Xue JD, Xie H, Fu Q, Feng C, Guo H, Xu YM: Single-staged improved tubularized preputial/penile skin flap urethroplasty for obliterated anterior urethral stricture: long-term results. Urol Int 2016, Epub ahead of print.
16.
Barbagli G, Perovic S, Djinovic R, Sansalone S, Lazzeri M: Retrospective descriptive analysis of 1,176 patients with failed hypospadias repair. J Urol 2010;183:207-211.
17.
Tonkin JB, Jordan GH: Management of distal anterior urethral strictures. Nat Rev Urol 2009;6:533-538.
18.
Pansadoro V, Emiliozzi P: Internal urethrotomy in the management of anterior urethral strictures: long-term followup. J Urol 1996;156:73-75.
19.
Cooperberg MR, McAninch JW, Alsikafi NF, Elliott SP: Urethral reconstruction for traumatic posterior urethral disruption: outcomes of a 25-year experience. J Urol 2007;178:2006-2010; discussion 2010.
20.
Cecen K, Karadag MA, Demir A, Kocaaslan R: Plasmakinetic™ versus cold knife internal urethrotomy in terms of recurrence rates: a prospective randomized study. Urol Int 2014;93:460-463.
21.
Barbagli G, De Angelis M, Romano G, Lazzeri M: Long-term followup of bulbar end-to-end anastomosis: a retrospective analysis of 153 patients in a single center experience. J Urol 2007;178:2470-2473.
22.
Fu Q, Zhang J, Sa YL, Jin SB, Xu YM: Transperineal bulboprostatic anastomosis in patients with simple traumatic posterior urethral strictures: a retrospective study from a referral urethral center. Urology 2009;74:1132-1136.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.